Potential new treatment to tackle commonest form of childhood cancer

A combination of two drugs could improve outcomes and reduce the need for toxic chemotherapy for B-cell acute lymphoblastic leukaemia (B-ALL), the commonest cancer in childhood and one that can be particularly difficult to treat in older patients, according to Cambridge scientists.

Read more: https://www.cam.ac.uk/stories/B-ALL-new-treatment